Trial on Education And Clinical Outcomes for Home PD Patients (TEACH) (TEACH)

April 12, 2016 updated by: Kook-Hwan Oh

Since the emergence of home peritoneal dialysis as an alternative to in-center hemodialysis for chronic renal replacement therapy in the late 1970s, the percentage of dialysis patients on PD has continued to decrease each year. There have been a growing concern and research on patient and technique survival of peritoneal dialysis versus hemodialysis to find influential factors for better clinical outcomes. Meanwhile, technique failure rates were significantly higher in small centers treating less than twenty five PD patients. And there was a result for better technique survival after the second year, among the patients trained at the BREC(Baxter Renal Education Center). Better technique survival in large centers can be assumed with not only their more experience with patient management but also their educational infrastructure compared to small-sized centers.

Throughout our experiences in the last 30 years, we have recognized that a major element of PD program is patient training, however few data are available in terms of the relationship between PD training and treatment outcome and mostly are retrospective and non-randomized. Moreover, the technique survival and patient survival were analyzed with no significant difference.

From the insight, we decided to study prospectively to evaluate the efficacy of well-structured education program in terms of various patient outcomes in incident patients on PD.

Study Overview

Status

Completed

Conditions

Detailed Description

This study will be conducted as multi-center, open-label, randomized, controlled trial. One hundred four patient starting PD will be randomized into two training groups. Patients in the conventional training group (CG) will be given non-standardized in-center conventional training programs plus two sessions of training by home visit, while those in intensive training group (IG) given in-center conventional training programs plus repeated home visits regularly over 24-month period (total thirteen visits). The primary end point of the study is exit site infection (ESI). Secondary endpoints are peritonitis and all-cause infection. Generalized Estimating Equations will be used to assess the adjusted effect of training level on the ESI and Cox regression model employed to evaluate the effect on the peritonitis and other secondary outcomes.

Study Type

Interventional

Enrollment (Actual)

104

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Anyang, Korea, Republic of
        • Hallym University Sacred Hospital Puyngchon
      • Incheon, Korea, Republic of
        • Gachon University Gil Hospital
      • Seoul, Korea, Republic of
        • Seoul National University Hospital
      • Seoul, Korea, Republic of
        • Eulji Medical Center
      • Seoul, Korea, Republic of
        • Hallym University Sacred Hospital Gangdong
    • Gyeonggi-do
      • Gunpo, Gyeonggi-do, Korea, Republic of
        • Wonkwang University, Sanbon Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Incident patients who have PD catheter insertion for starting PD with Baxter solutions
  • > 20 yr of age

Exclusion Criteria:

  • Patients who have undergone dialysis or received kidney transplant (note, however, that patients who are currently undergoing emergency hemodialysis temporarily right before the PD do not fall under the exclusion criteria.)
  • Patients who are likely to receive kidney transplant or shift to hemodialysis within the following 1 year
  • Patients diagnosed with acute inflammatory disease for the past three months
  • Patients currently diagnosed with chronic inflammatory disease
  • Currently pregnant or breastfeeding
  • Patients who are involved in other clinical trial within 30 days prior to enrollment
  • Patients who are currently hospitalized in care facilities such as nursing home, etc., or those who are expected to be hospitalized for the duration of the clinical test
  • Patients who cannot perform PD by themselves
  • Patients considered by the person in charge of the clinical test to have difficulty in participating in this clinical test

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Conventional training group
in-center conventional training programs + two home visits
Experimental: Intensive training group
in-center conventional training programs + an extra structured patient home visits repeatedly and regularly
an extra structured patient centric training program on PD technique and diet according to the developed training curriculum

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Exit site infection
Time Frame: 24 months
24 months

Secondary Outcome Measures

Outcome Measure
Time Frame
time to the first peritonitis
Time Frame: 24 months
24 months
Number of ESIs per patient-month
Time Frame: 24 months
24 months
Days of hospitalization per year
Time Frame: 24 months
24 months
Systolic pressure and diastolic pressure measured at every visit
Time Frame: 24 months
24 months
Average number of antihypertensive medications
Time Frame: 24 months
24 months
Kt/V
Time Frame: 24 months
24 months
Residual renal function
Time Frame: 24 months
24 months
Fluid balance score
Time Frame: 24 months
24 months
Patient survival rate
Time Frame: 24 months
24 months
Total medical cost
Time Frame: 24 months
24 months
Total hours of education and training
Time Frame: 24 months
24 months
Unplanned home visit and education by peritoneal dialysis nurse
Time Frame: 24 months
24 months
Compliance score of patients
Time Frame: 24 months
24 months
HbA1c only for patients with diabetes
Time Frame: 24 months
24 months
Intact PTH level
Time Frame: 24 months
24 months
Hemoglobin level
Time Frame: 24 months
24 months
nPNA
Time Frame: 24 months
24 months
QOL
Time Frame: 24 months
24 months
SGA
Time Frame: 24 months
24 months
K level
Time Frame: 24 months
24 months
Total number of hospitalizations by cause over the last 1 and/or 2 years after the dialysis
Time Frame: 24 months
24 months
Technical survival rate
Time Frame: 24 months
24 months
peritonitis rate
Time Frame: 24 months
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Kook-Hwan Oh, M.D., PhD, Seoul National University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2010

Primary Completion (Actual)

July 1, 2015

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

September 16, 2010

First Submitted That Met QC Criteria

September 16, 2010

First Posted (Estimate)

September 17, 2010

Study Record Updates

Last Update Posted (Estimate)

April 14, 2016

Last Update Submitted That Met QC Criteria

April 12, 2016

Last Verified

April 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • TEACH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Risk Reduction

Clinical Trials on Intensive training group

3
Subscribe